36-Month Performance of a Sirolimus-Eluting Balloon in Diabetic and Nondiabetic Patients With Femoropopliteal Artery Disease From the SELUTION SFA Japan Study
Tuesday, November 4, 20255:15pm - 5:30pm PT
